Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes

Heart failure (HF) and type 2 diabetes mellitus (T2DM) are two growing and related diseases in general population and particularly in elderly people. In selected patients affected by HF and severe dysfunction of left ventricle ejection fraction (LVEF), with left bundle brunch block, the cardiac resy...

Full description

Saved in:
Bibliographic Details
Main Authors: Celestino Sardu, Michelangela Barbieri, Maria Rosaria Rizzo, Pasquale Paolisso, Giuseppe Paolisso, Raffaele Marfella
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2016/7292564
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567408460562432
author Celestino Sardu
Michelangela Barbieri
Maria Rosaria Rizzo
Pasquale Paolisso
Giuseppe Paolisso
Raffaele Marfella
author_facet Celestino Sardu
Michelangela Barbieri
Maria Rosaria Rizzo
Pasquale Paolisso
Giuseppe Paolisso
Raffaele Marfella
author_sort Celestino Sardu
collection DOAJ
description Heart failure (HF) and type 2 diabetes mellitus (T2DM) are two growing and related diseases in general population and particularly in elderly people. In selected patients affected by HF and severe dysfunction of left ventricle ejection fraction (LVEF), with left bundle brunch block, the cardiac resynchronization therapy with a defibrillator (CRT) is the treatment of choice to improve symptoms, NYHA class, and quality of life. CRT effects are related to alterations in genes and microRNAs (miRs) expression, which regulate cardiac processes involved in cardiac apoptosis, cardiac fibrosis, cardiac hypertrophy and angiogenesis, and membrane channel ionic currents. Different studies have shown a different prognosis in T2DM patients and T2DM elderly patients treated by CRT-D. We reviewed the literature data on CRT-D effect on adult and elderly patients with T2DM as compared with nondiabetic patients.
format Article
id doaj-art-dc0b5519bc37487c8e2bd6425c64accb
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-dc0b5519bc37487c8e2bd6425c64accb2025-02-03T01:01:37ZengWileyJournal of Diabetes Research2314-67452314-67532016-01-01201610.1155/2016/72925647292564Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA ChangesCelestino Sardu0Michelangela Barbieri1Maria Rosaria Rizzo2Pasquale Paolisso3Giuseppe Paolisso4Raffaele Marfella5Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyDepartment of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyDepartment of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyDepartment of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyDepartment of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyDepartment of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, 80138 Naples, ItalyHeart failure (HF) and type 2 diabetes mellitus (T2DM) are two growing and related diseases in general population and particularly in elderly people. In selected patients affected by HF and severe dysfunction of left ventricle ejection fraction (LVEF), with left bundle brunch block, the cardiac resynchronization therapy with a defibrillator (CRT) is the treatment of choice to improve symptoms, NYHA class, and quality of life. CRT effects are related to alterations in genes and microRNAs (miRs) expression, which regulate cardiac processes involved in cardiac apoptosis, cardiac fibrosis, cardiac hypertrophy and angiogenesis, and membrane channel ionic currents. Different studies have shown a different prognosis in T2DM patients and T2DM elderly patients treated by CRT-D. We reviewed the literature data on CRT-D effect on adult and elderly patients with T2DM as compared with nondiabetic patients.http://dx.doi.org/10.1155/2016/7292564
spellingShingle Celestino Sardu
Michelangela Barbieri
Maria Rosaria Rizzo
Pasquale Paolisso
Giuseppe Paolisso
Raffaele Marfella
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
Journal of Diabetes Research
title Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
title_full Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
title_fullStr Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
title_full_unstemmed Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
title_short Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes
title_sort cardiac resynchronization therapy outcomes in type 2 diabetic patients role of microrna changes
url http://dx.doi.org/10.1155/2016/7292564
work_keys_str_mv AT celestinosardu cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges
AT michelangelabarbieri cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges
AT mariarosariarizzo cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges
AT pasqualepaolisso cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges
AT giuseppepaolisso cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges
AT raffaelemarfella cardiacresynchronizationtherapyoutcomesintype2diabeticpatientsroleofmicrornachanges